Join companies like...
Arcinova - Asymchem - Atomwise - Bayer - C3 Research Associates - Early Drug Development Group - GI Innovation - Holy Stone Healthcare - Idifarma - Impact Therapeutics - Innate Biotherapeutics - Inovotion - Jubilant Therapeutics Inc - Kaer Labs - Labatec Pharma - Medicon Valley Alliance - Medincell - Mereo BioPharma - Nanorobotics Ltd. - NovaRock Bio - Oncurious NV - Orion Pharma - Prescient Therapeutics - Purple Biotech - Sudair Pharma - Tanner Pharma - Trio Pharmaceuticals, Inc. - Viracta Therapeutics, Inc. - Virogin Biotech
Companies profile
Attendees profile
Asset phase
“HalioDx, a leader in immuno-oncology diagnostics and CRO partner for oncologists and BioPharma is coming to Oncology Virtual Partnering to present our first-in-class multi-omic based programs that draw on our expertise and focus on immuno-oncology. The targeted one-on-one meetings specifically focused on oncology will allow us to identify the innovative partners for these collaborations. ”
“Prescient Therapeutics is excited to participate in Oncology Virtual Partnering to discuss our novel next-generation CAR-T/CAR-NK technology platform - OmniCAR. The targeted one-on-one meetings and easy-to-use partnering system allow us to discuss our modular, controllable CAR-T technology with partners looking to add post-infusion safety and control to their own CAR-T/NK programs. ”
Why participate?
Find potential R&D collaborations or oncology assets available for in-licensing/acquisition
Identify partners with research solutions such as high throughput screening tools, clinical research capacity, or animal models
Secure funding from new investors or find licensing partners for your portfolio
Discover new diagnostics, biomarkers, adjuvants, carrier systems or technologies
Who will attend?
The Oncology Virtual Partnering Event will bring these stakeholders together to pursue:
Potential R&D collaborations
Early stage discovery collaboration
Drug repurposing
Biological markers and diagnostic tests
Adjuvants, carrier systems, and formulation technologies
Tools for research projects
Animal and in-silico models
Funding and investors
Partners for clinical trials